Fluoxetine hydrochloride, 99%
Fluoxetine hydrochloride, 99%
Fluoxetine hydrochloride, 99%
Fluoxetine hydrochloride, 99%
Thermo Scientific Chemicals

Fluoxetine hydrochloride, 99%

A selective serotonin reuptake inhibitor | CAS: 56296-78-7 | C17H19ClF3NO | 345.79 g/mol
Have Questions?
货号数量
J61197.MD
又称 J61197-MD
250 mg
货号 J61197.MD
又称 J61197-MD
价格(CNY)
-
数量:
250 mg
请求批量或定制报价
化学标识符
CAS56296-78-7
IUPAC Namehydrogen methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine chloride
Molecular FormulaC17H19ClF3NO
InChI KeyGIYXAJPCNFJEHY-UHFFFAOYNA-N
SMILES[H+].[Cl-].CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
查看更多内容
规格Specification Sheet规格表
Appearance (Color)White
Assay from Supplier's CofA≥98.5% (HPLC)
FormCrystalline powder
Fluoxetine hydrochloride is a selective serotonin reuptake inhibitor. It is used to treat major depressive disorder, bulimia nervosa (an eating disorder) obsessive-compulsive disorder, panic disorder and premenstrual dysphoric disorder (PMDD).

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
Fluoxetine hydrochloride is a selective serotonin reuptake inhibitor. It is used to treat major depressive disorder, bulimia nervosa (an eating disorder) obsessive-compulsive disorder, panic disorder and premenstrual dysphoric disorder (PMDD).

Solubility
Soluble in dimethylsulfoxide and water.

Notes
Incompatible with strong oxidizing agents.
RUO – Research Use Only

General References:

  1. Huang, C.; Seip, K. F.; Gjelstad, A.; Shen, X.; Pedersen-Bjergaard, S. Combination of Electromembrane Extraction and Liquid-Phase Microextraction in a Single Step: Simultaneous Group Separation of Acidic and Basic Drugs. Anal. Chem. 2015, 87 (13), 6951-6957.
  2. Chakravarty, P.; Kothari, S.; Deese, A.; Lubach. J. W. Solid-State Characterization of Novel Propylene Glycol Ester Solvates Isolated from Lipid Formulations. Mol. Pharmaceutics. 2015, 12 (7), 2551-2557.